Flerie AB (publ)
Research Flerie AB (publ) (1NP1) on Bullrun: market cap EUR 138.72M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker1NP1
- ExchangeF
- CountrySweden
- SectorHealthcare
- IndustryBiotechnology
- CurrencyEUR
- Market capEUR 138.72M
- Financial periodQ2 2026
- RevenueSEK 1.30M
- Net income-SEK 92.40M
- Free cash flow-SEK 9.10M
Valuation Snapshot
latest market cap is EUR 138.72M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | n/a | n/a | n/a | n/a | -9.54 | SEK 540.20M | SEK 2.10M | SEK 3.38B |
| FY2024 | SEK 100.00K | -SEK 228.00M | n/a | n/a | n/a | SEK 865.10M | SEK 800.00K | SEK 4.20B |
| FY2023 | SEK 0 | -SEK 559.60M | n/a | n/a | n/a | SEK 330.00M | n/a | SEK 3.57B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-27 | EUR 138.72M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 EUR.
About Flerie AB (publ)
Flerie AB (publ) is a venture capital firm specializing in early-stage investments. The firm seeks to invest in life science, biotech and pharma companies engaged in drug development and associated tools or applications tackling major medical challenges of our time. The firm seeks to invest in Europe, Nordic, United States and Israel. Flerie AB (publ) was founded in 2011 and is based in Stockholm, Sweden with additional office in London, United Kingdom.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Flerie AB (publ)'s market cap?
Flerie AB (publ)'s market capitalization is EUR 138.72M.
What does Flerie AB (publ) do?
Flerie AB (publ) is a venture capital firm specializing in early-stage investments. The firm seeks to invest in life science, biotech and pharma companies engaged in drug development and associated tools or applications tackling major medical challenges of our time. The firm seeks to invest in Europe, Nordic, United States and Israel. Flerie AB (publ) was founded in 2011 and is based in Stockholm, Sweden with additional office in London, United Kingdom.